Literature DB >> 12640620

Versatile inducible activation system of Akt/PKB signaling pathway in mice.

Jens Kroll1, Patricia Cobo, Thomas N Sato.   

Abstract

We report a transgenic mouse line in which Akt/protein kinase B (PKB) pathway can be activated in an inducible manner in defined cell types. In this transgenic mouse line, Cre expression allows the expression of a tamoxifen-activatable form of Akt/PKB in a defined cell type. Subsequent injection of tamoxifen triggers the transient activation of Akt/PKB in mice. Thus, this transgenic line allows the transient activation of Akt/PKB pathway in a predefined cell type. We expect that this transgenic system will provide a unique tool to study the roles of Akt/PKB pathway in mice. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12640620     DOI: 10.1002/gene.10180

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  2 in total

1.  Stage-specific disruption of Stat3 demonstrates a direct requirement during both the initiation and promotion stages of mouse skin tumorigenesis.

Authors:  Ken Kataoka; Dae Joon Kim; Steve Carbajal; John L Clifford; John DiGiovanni
Journal:  Carcinogenesis       Date:  2008-05-02       Impact factor: 4.944

2.  Comparative Analysis of Muscle Hypertrophy Models Reveals Divergent Gene Transcription Profiles and Points to Translational Regulation of Muscle Growth through Increased mTOR Signaling.

Authors:  Marcelo G Pereira; Kenneth A Dyar; Leonardo Nogara; Francesca Solagna; Manuela Marabita; Martina Baraldo; Francesco Chemello; Elena Germinario; Vanina Romanello; Hendrik Nolte; Bert Blaauw
Journal:  Front Physiol       Date:  2017-12-04       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.